Aminoglutethimide

Aminoglutethimide (brand name Cytadren) is a medication used to treat certain types of breast cancer and Cushing's syndrome. It is a glucocorticoid inhibitor, which works by preventing the production of hormones in the adrenal gland, such as cortisol. This can help to reduce symptoms of Cushing's syndrome and slow the growth of certain breast cancer cells. Aminoglutethimide may also be used as part of a combination therapy to treat other types of cancer. It is available in tablet form and is usually taken twice a day.

Aminoglutethimide, previously sold under brand names like Cytadren and Elipten, is a medication with a complex history in the medical field. While it has been used for various purposes, it is no longer widely recommended due to the availability of safer and more effective alternatives. Here's a breakdown of its key points:

Historical Uses:

  • Anticonvulsant: In the past, it was used to treat petit mal epilepsy (a type of absence seizure). However, safer and more effective anticonvulsant medications have become available.
  • Steroidogenesis inhibitor: It has been used to inhibit the production of certain hormones by interfering with their synthesis pathway. This was applied in:
    • Cushing's syndrome: To manage excessive cortisol (stress hormone) production.
    • Postmenopausal breast cancer: To block estrogen production, potentially slowing cancer growth (required additional hormone replacement therapy to avoid side effects).
    • Prostate cancer: To reduce testosterone levels and potentially slow cancer progression.

Current Status:

  • Limited use: Due to the emergence of safer and more effective medications for the conditions mentioned above, aminoglutethimide is not commonly used in modern medical practice.
  • Reduced availability: Less demand and the presence of safer alternatives have led to limited market availability of aminoglutethimide.
  • Not recommended: It is not recommended as a first-line treatment due to several factors:
    • Side effects: It can cause drowsiness, rash, hair loss, and potentially serious bone marrow suppression.
    • Drug interactions: It can interact with various medications, increasing the risk of side effects.

Important Note:

  • This information is for general knowledge only and should not be interpreted as medical advice.
  • Always consult with a qualified healthcare professional for any questions or concerns regarding your specific situation and treatment options. They can provide the most up-to-date and personalized advice based on your individual needs and medical history.

 

Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L02 Endocrine therapy
L02B - Hormone antagonists and related agents
L02BG Aromatase inhibitors
External Links